From Legacy Roots to Global Growth
We are MTL Cannabis Corp.
A leader in premium craft cannabis, medical cannabis distribution, and exporter to international medical cannabis markets.
From our legacy market roots to our position as a publicly traded company, we grow with purpose, precision, and passion.
THE NEWS
Latest & Greatest
SMITHS FALLS, Ontario & POINTE-CLAIRE, Quebec--( BUSINESS WIRE )--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) and MTL Cannabis Corp. (“MTL Cannabis” or “MTL”) (CSE: MTLC) (OTCQX: MTLNF) are pleased to announce that they have entered into a definitive arrangement agreement (the “Arrangement Agreement”) pursuant to which Canopy Growth will acquire all of the issued and outstanding common shares of MTL (the “MTL Shares”) and will settle all debt and debt-like instruments owed by MTL, in a transaction valued at approximately $125 million on a fully-diluted equity basis (the “Transaction”) and approximately $179 million on an enterprise value (“TEV”) basis. Under the terms of the Arrangement Agreement, each shareholder of MTL (an “MTL Shareholder”) will receive fixed consideration for each MTL Share equal to: (i) 0.32 of a common share of Canopy Growth (each whole share, a “Canopy Growth Share”), and (ii) $0.144 in cash.
PICKERING, ON, le 28 nov. 2025 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) (OTCQX: MTLNF) (« MTL » ou la « Société ») a le plaisir d'annoncer le dépôt de ses états financiers pour les périodes de trois mois et de six mois se terminant les 30 septembre 2025 et 2024. Vous trouverez tous les détails dans le profil SEDAR+ de la Société à www.sedarplus.ca . Faits saillants financiers consolidés du deuxième trimestre de 2025 : La Société a réalisé un revenu de 25 365 570 $ pendant le deuxième trimestre de l'exercice 2026 par rapport à 26 434 502 $ lors du trimestre correspondant de l'exercice financier précédent. La Société a réalisé un revenu net de 20 613 664 $ pendant le deuxième trimestre de l'exercice 2026 par rapport à 20 869 898 $ lors du trimestre correspondant de l'exercice financier précédent. La Société a réalisé des marges brutes avant ajustements de la juste valeur de 50 % pendant le deuxième trimestre de l'exercice 2026, soit une augmentation de 7 % par rapport au trimestre précédent, et une baisse de 4 % par rapport à 54 % au même trimestre de l'exercice financier précédent. La Société continue de réaliser un BAIIA ajusté positif de 2 223 919 $ pendant le deuxième trimestre de l'exercice 2026. (1) Voir la section « Mesures financières non conformes aux IFRS » ci-dessous pour le rapprochement du BAIIA et du BAIIA ajusté.
PICKERING, ON, Nov. 28, 2025 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) (OTCQX: MTLNF) ("MTL" or the "Company") is pleased to report it has filed its financial statements as at and for the three-month and six-month periods ending September 30, 2025, and 2024. Complete details may be found on the Company's SEDAR+ profile at www.sedarplus.ca . Second Quarter 2025 Consolidated Financial Highlights: The Company generated revenue of $25,365,570 during the second quarter of fiscal 2026, compared to $26,434,502 in the same quarter of last fiscal year. The Company generated net revenue of $20,613,664 during the second quarter of fiscal 2026, compared to $20,869,898 in the same quarter of last fiscal year. The Company generated gross margins before fair value adjustments of 50% during the second quarter of fiscal 2026, an increase of 7% over the previous fiscal quarter, and a decrease of 4%, compared to 54% in the same quarter of last fiscal year. The Company continues to generate positive Adjusted EBITDA of $2,223,919 during the second quarter of fiscal 2026. (1) See "Non-IFRS financial measures" section below for reconciliation of EBITDA and Adjusted EBITDA.
WE GROW
WITH PURPOSE
Our mission is to raise the standard for cannabis worldwide. Guided by passion, credibility, and an unwavering commitment to quality, we cultivate more than cannabis — we cultivate trust. Every product we grow and every partnership we build strengthens our community of consumers, patients, employees, and investors.
OUR BRANDS
We are proud to steward a growing portfolio of award-winning cannabis brands designed to meet diverse consumer needs.
